Dr. Benjamin Cook -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Benjamin Cook, a Cardiology physician based in Philadelphia, PA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Benjamin Cook has received $3,950.78 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Benjamin Cook has received a total of $3,950.78 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $3,950.78 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Benjamin Cook's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Consulting Fees$3,950.78Advisory board participation, clinical consulting, and expert opinion services

The largest payment category for Dr. Benjamin Cook is Consulting Fees, accounting for 100% ($3,950.78) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Benjamin Cook. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Amgen Inc$3,950.781

Dr. Benjamin Cook has a financial relationship with Amgen Inc, receiving $3,950.78 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Benjamin Cook's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Benjamin Cook has received $4.0K across 1 pharmaceutical payments as a Cardiology physician in Philadelphia, PA. Top paying companies include Amgen Inc ($4.0K). The doctor received a single payment totaling $3,951 in 2025. This payment was for consulting services. The entire amount came from a single pharmaceutical company, Amgen Inc.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Benjamin Cook is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

When consulting with a healthcare provider, consider asking about any potential conflicts of interest or relationships they may have with pharmaceutical companies, especially if they recommend specific medications. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Benjamin Cook Compares to Other Cardiology Physicians

For a Cardiology specialist, receiving a single consulting payment from a pharmaceutical company is not uncommon, though transparency is enhanced with multiple, smaller payments from diverse sources.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Benjamin Cook in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Amgen Inc$3,950.78consultingN/A2025-03-04Not Assessed

Frequently Asked Questions About Dr. Benjamin Cook's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Benjamin Cook received?

Benjamin Cook has received a total of $4.0K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Benjamin Cook taking too much pharma money?

Benjamin Cook has received $4.0K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Cardiology), the types of payments, and how they compare to peers. The largest payment category is consulting ($4.0K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Benjamin Cook?

The top pharmaceutical companies paying Benjamin Cook are: Amgen Inc ($4.0K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Benjamin Cook receive?

Benjamin Cook's payments by type: consulting: $4.0K. Consulting fees suggest active advisory roles with pharmaceutical companies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Benjamin Cook's payments compare to other Cardiology doctors?

To compare, look at the total amount ($4.0K), number of payments (1), and the types of payments received. Cardiology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Benjamin Cook's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1575454952). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Benjamin Cook's pharma payment profile?

The doctor's payment profile is highly concentrated, with 100% of the total amount originating from one company. Benjamin Cook has received $4.0K in total pharma payments.

How does Benjamin Cook compare to peers in Cardiology?

For a Cardiology specialist, receiving a single consulting payment from a pharmaceutical company is not uncommon, though transparency is enhanced with multiple, smaller payments from diverse sources.

Are Benjamin Cook's pharma relationships typical for Cardiology?

The single payment represents the entirety of the doctor's reported pharma payments for the analyzed period.

What should patients of Benjamin Cook know about these payments?

When consulting with a healthcare provider, consider asking about any potential conflicts of interest or relationships they may have with pharmaceutical companies, especially if they recommend specific medications.

What patterns are visible in Benjamin Cook's payment history?

The doctor's specialty is Cardiology, which often involves discussions about medication efficacy and patient treatment plans.

Understanding This Doctor Payment Report

This transparency report for Dr. Benjamin Cook is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Benjamin Cook's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Benjamin Cook and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.